← Back to Investors

MPM BioImpact

MPM BioImpact is a life sciences venture fund focused on therapeutics investments. Part of the broader MPM Capital platform, they specialize in innovative biotechnology companies with potential for significant patient impact and commercial success.

Location
Boston, Massachusetts, USA
Founded
2018
AUM
$450M+
Investment Range
$5M - $50M
Focus
biotech-focused
Fund Stages
seed, series-a, series-b, series-c, growth

Investment Thesis

MPM BioImpact invests in innovative therapeutics companies that can make a meaningful impact on patient lives. They focus on companies with differentiated science, strong management teams, and clear paths to clinical development and regulatory approval.

Team

Partners / Managing Directors (Health & Bio Focus)

  • Ansbert Gadicke, MD - Co-Founder & Managing Partner
  • Todd Foley - Managing Partner
  • Luke Evnin, PhD - Founding Partner (MPM Capital)

Other Key Team Members

  • Investment team with deep pharma and biotech experience

Focus Areas

  • Therapeutics (oncology, rare diseases)
  • Biotechnology
  • Drug discovery
  • Novel modalities
  • Company creation
  • Platform technologies

Notable Investments

  • Multiple therapeutics companies across oncology and rare diseases
  • Strong track record in biotech company building

Sources